1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,210 | 1,270 | 23.12. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| GAUSH MEDITECH Aktie jetzt für 0€ handeln | |||||
| 18.11. | GAUSH MEDITECH (02407): VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE SHARE AWARD SCHEME | 1 | HKEx | ||
| 18.11. | GAUSH MEDITECH (02407): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 13.11. | GAUSH MEDITECH (02407): VOLUNTARY ANNOUNCEMENT INTRAOCULAR LENS IMPLANT SYSTEM OBTAINED MEDICAL DEVICE REGISTRATION CERTIFICATE | - | HKEx | ||
| 26.09. | GAUSH MEDITECH (02407): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS - NOTIFICATION OF PUBLICATION OF INTERIM REPORT 2024 | - | HKEx | ||
| 26.09. | GAUSH MEDITECH (02407): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTIFICATION OF PUBLICATION OF INTERIM REPORT 2024 | 1 | HKEx | ||
| 26.09. | GAUSH MEDITECH (02407): INTERIM REPORT 2024 | 3 | HKEx | ||
| 09.09. | GAUSH MEDITECH (02407): VOLUNTARY ANNOUNCEMENT TECHNICAL COOPERATION AGREEMENT WITH GEUDER ON THE SOLUTION OF PHACOEMULSIFICATION AND VITRECTOMY SURGERY | - | HKEx | ||
| 28.08. | GAUSH MEDITECH (02407): VOLUNTARY ANNOUNCEMENT ADOPTION OF SHARE AWARD SCHEME | 1 | HKEx | ||
| 28.08. | GAUSH MEDITECH (02407): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024 | 2 | HKEx | ||
| 16.08. | GAUSH MEDITECH (02407): NOTICE OF BOARD MEETING | 1 | HKEx | ||
| 02.08. | GAUSH MEDITECH (02407): PROFIT UPDATE IN RESPECT OF THE FINANCIAL INFORMATION FOR THE SIX MONTHS ENDED JUNE 30, 2024 | - | HKEx | ||
| 30.07. | GAUSH MEDITECH (02407): VOLUNTARY ANNOUNCEMENT TWO DIAGNOSTIC DEVICES FOR DRY EYES OBTAINED MEDICAL DEVICE REGISTRATION CERTIFICATES | 1 | HKEx | ||
| 24.07. | GAUSH MEDITECH (02407): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 23.07. | GAUSH MEDITECH (02407): NEXT DAY DISCLOSURE RETURNS | 1 | HKEx | ||
| 15.07. | GAUSH MEDITECH (02407): NEXT DAY DISCLOSURE RETURN | - | HKEx |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AVINGER | 1,380 | +114,82 % | Avinger Inc - 8-K, Current Report | ||
| PROCEPT BIOROBOTICS | 83,46 | +2,85 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GENEDX | 76,75 | +0,46 % | GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported its financial results for the third... ► Artikel lesen | |
| NANO-X IMAGING | 7,015 | -0,78 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| RXSIGHT | 34,305 | -0,82 % | RxSight cut to hold at Stifel on competition concerns | ||
| EUROPEAN WAX CENTER | 5,405 | +4,95 % | European Wax Center, Inc. Reports Third Quarter Fiscal Year 2024 Results | Reiterates fiscal 2024 financial outlook Updates fiscal 2024 outlook for net new centers Third Quarter Fiscal 2024 versus 2023 Net new centers increased 3.7% to 1,064 total centers in 45 statesSystem-wide... ► Artikel lesen | |
| 908 DEVICES | 1,880 | -1,05 % | 908 Devices stock hits 52-week low at $1.82 amidst market challenges | ||
| CASTLE BIOSCIENCES | 27,490 | +0,04 % | Castle Biosciences plant Markteinführung von Neurodermitis-Test bis Ende 2025 | ||
| CVRX | 12,835 | +2,68 % | CVRx, Inc.: CVRx Reports Third Quarter 2024 Financial and Operating Results | MINNEAPOLIS, Oct. 29, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation... ► Artikel lesen | |
| TALKSPACE | 3,040 | +1,33 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| CLEARPOINT NEURO | 15,620 | +6,77 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain | Only Device Approved to Deliver First Disease-Modifying Treatment for AADC Deficiency in the United StatesSOLANA BEACH, CA / ACCESSWIRE / November 13, 2024 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the... ► Artikel lesen | |
| WORK MEDICAL TECHNOLOGY GROUP | 4,670 | -5,08 % | WORK Medical Technology Group LTD - F-1, Registration statement for certain foreign private issuers | ||
| ALIGNMENT HEALTHCARE | 10,610 | -0,93 % | Alignment Healthcare Reports Third Quarter 2024 Results | Reports $692.4 million in total revenue, up 51.6% year-over-year Increases Medicare Advantage membership, up 57.7% year-over-year to approximately 182,300 members, beating third-quarter and year-end... ► Artikel lesen | |
| PROGYNY | 14,480 | -0,07 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
| ADAPTHEALTH | 10,070 | -0,98 % | AdaptHealth Corp. Announces Third Quarter 2024 Results | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen |
GAUSH MEDITECH LTD gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,030 (-2,46 %) liegt der Kurs bei 1,190 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GAUSH MEDITECH LTD finden Sie auf Wallstreet Online.
